Naphazoline Hydrochloride and Pheniramine Maleate

Manufacturer
Walgreens | Akorn, Inc. | Akorn, Inc
Effective date
2013-04-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 01:35:18

Label at a glance#

ProductNaphazoline Hydrochloride and Pheniramine Maleate
Active ingredientNaphazoline Hydrochloride, Pheniramine Maleate
Label structure11 sections

Indications and uses

Temporarily relieves itchy, red eyes due to: pollen ragweed grass animal hair and dander

Dosage and administration

adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day children under 6 years of age: consult a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Naphazoline Hydrochloride 0.025%

Pheniramine Maleate 0.3%

Purpose

OTC - PURPOSE SECTION

Redness reliever

Antihistamine

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves itchy, red eyes due to:

  • pollen
  • ragweed
  • grass
  • animal hair and dander

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use if you are sensitive to any ingredient in this product

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • heart disease
  • high blood pressure
  • narrow angle glaucoma
  • trouble urinating due to an enlarged prostate gland

When using this product

OTC - WHEN USING SECTION

  • pupils may become enlarged temporarily
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after each use
  • remove contact lenses before using
  • do not use if this solution changes color or becomes cloudy
  • overuse may cause more eye redness

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Accidental swallowing by infants and children may lead to coma and marked reduction in body temperature.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day
  • children under 6 years of age: consult a doctor

Other information

SPL UNCLASSIFIED SECTION

  • some users may experience a brief tingling sensation
  • store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Boric Acid and Sodium Borate buffer system preserved with Benzalkonium Chloride (0.01%) and Edetate Disodium (0.1%), Sodium Hydroxide and/or Hydrochloric Acid(to adjust pH) and Water for Injection.

Questions or Comments?

OTC - QUESTIONS SECTION

1-800-932-5676

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Container Label:

Well at

Walgreens

NDC 0363-9650-02

STERILE

Allergy

Eye Drops

Naphazoline HCl 0.025% and

Pheniramine Maleate 0.3%

Ophthalmic Solution, USP

Antihistamine & Redness Reliever

Relieves redness & itchy eyes

0.5 FL OZ (15 mL)

Principal Display Panel Text for Container Label
Principal Display Panel Text for Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Carton Label:

Well at

Walgreens

NDC 0363-9650-02

WALGREENS PHARMACIST RECOMMENDED‡

STERILE

Allergy

Eye Drops

Naphazoline HCl 0.025% and

Pheniramine Maleate 0.3%

Ophthalmic Solution, USP

Antihistamine & Redness Reliever

Relieves redness &

itchy eyes due to:

  • Pollen
  • Ragweed ● Grass
  • Animal hair & dander

Compare to Visine-A® active ingredients#

0.5 FL OZ (15 mL)

Principal Display Panel Text for Carton Label
Principal Display Panel Text for Carton Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0363-9650-022020-10-23C16284748780-19d75b9d0-1bf4-f424-e053-dadaa90a57ce2f0592a4-af44-464b-8d08-7727c2fc1ca8
0363-9650-022020-01-31C16284748780-19d75b9d0-1bf4-f424-e053-dadaa90a57ce2f0592a4-af44-464b-8d08-7727c2fc1ca8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0363-9650-02ML - Milliliter0363-9650c75849ce-1fb6-4981-b360-5a9ec87f90c712016-03-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Naphazoline HydrochlorideACTIVE INGREDIENTMZ1131787D2
Pheniramine MaleateACTIVE INGREDIENTNYW905655B2
NaphazolineACTIVE MOIETYH231GF11BV2
PheniramineACTIVE MOIETY134FM9ZZ6M2
Benzalkonium ChlorideINACTIVE INGREDIENTF5UM2KM3W72
Boric AcidINACTIVE INGREDIENTR57ZHV85D42
Edetate DisodiumINACTIVE INGREDIENT7FLD91C86K2
Hydrochloric AcidINACTIVE INGREDIENTQTT17582CB2
Sodium BorateINACTIVE INGREDIENT91MBZ8H3QO2
Sodium HydroxideINACTIVE INGREDIENT55X04QC32I2
WaterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0363-96500363-9650-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 8 · 446 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Edetate DisodiumEDETATE DISODIUM7FLD91C86KSUSPENSION / ORAL30 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ICAPSULE, LIQUID FILLED / ORAL1.5 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium BorateSODIUM BORATE91MBZ8H3QOSOLUTION / OPHTHALMIC2 mgExact identifier — unii candidate
6 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSPRAY, METERED / RESPIRATORY (INHALATION)ADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRASPINALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSOLUTION / INTRAMUSCULARADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KPOWDER, FOR SUSPENSION / ORAL285 mgExact identifier — unii candidate
77 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRASYNOVIALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION / URETHRALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KSOLUTION / ORAL432 mgExact identifier — unii candidate
77 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KSYSTEM / TOPICAL126 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IEMULSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULARADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSUSPENSION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION, SOLUTION / SUBMUCOSALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KSPRAY, METERED / NASAL4 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IGEL, METERED / TRANSDERMAL350 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / ORAL11 mgExact identifier — unii candidate
174 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KINJECTION, SUSPENSION / INTRA-ARTICULAR1 mgExact identifier — unii candidate
77 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSUSPENSION / ORAL100 mgExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSOLUTION / URETERALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IPASTE / DENTAL0.6 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSOLUTION / INTRAVENOUS18.25 mgExact identifier — unii candidate
148 equally ranked IID candidates
Benzalkonium ChlorideBENZALKONIUM CHLORIDEF5UM2KM3W7CLOTH / TOPICALNAExact identifier — unii candidate
24 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBCAPSULE, LIQUID FILLED / ORALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KGEL / OPHTHALMIC396 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAVENOUS2.78 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRATHECAL176 mgExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULARADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IGEL / OPHTHALMIC6 mgExact identifier — unii candidate
174 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS0.4 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTRA-AMNIOTICADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSUSPENSION/ DROPS / TOPICALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Boric AcidBORIC ACIDR57ZHV85D4INJECTION, SOLUTION / INTRAVENOUS210 mgExact identifier — unii candidate
17 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRAPERITONEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Boric AcidBORIC ACIDR57ZHV85D4SOLUTION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
17 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION, SUSPENSION / INTRAMUSCULARADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBINJECTION / INTERSTITIALADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ITABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR27 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRAMUSCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / SUBMUCOSALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRASYNOVIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / SUBCUTANEOUS1 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KEMULSION / OPHTHALMIC0.3 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
Hydrochloric AcidHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
148 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / URETHRALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATENAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-2484e616aacf4f…
2026-08-18 06:07:402026-07A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-246a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-2403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-242680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-245bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-2479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-241e350fbaab3a…
2024-05-31 18:47 UTC2024-05A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-248072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-245c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-245d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-244b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-2474a2ff9319b5…
2022-03-09 01:35 UTC2022-03A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-2487673890dc5c…
2021-03-12 10:30 UTC2021-03A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-245aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-248869cabd3fbd…
2020-11-12 02:37 UTC2020-11A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24c0c555d07b60…
2019-12-14 00:12 UTC2019-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-243f01610625f2…
2019-09-15 20:21 UTC2019-09A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24b00525d2431f…
2019-07-19 19:46 UTC2019-07A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-246a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-241c564ffb4f44…
2023-12-20 04:57 UTC2023-12A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-249b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-243f0d92c62455…
2023-05-13 08:27 UTC2023-05A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24053a50430f4f…
2023-01-26 05:58 UTC2023-01A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-243bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-243a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A202795-001NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE0.025%;0.3%SOLUTION/DROPS / OPHTHALMIC2013-01-24f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3e55c678-e525-4a9c-9cdf-56192bf6d5ef2f0592a4-af44-464b-8d08-7727c2fc1ca82020-10-23WarningsExact identifier
spl set id: 2f0592a4-af44-464b-8d08-7727c2fc1ca8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.